Hepion Pharmaceuticals, Inc.
Biotech NJ
$700k raised
Ranked #34 of 47 Biotech filings in April 2026 by offering amount.
Median Biotech filing in April 2026: $3M. This offering is 0.3× the median.
Other Tennessee filings this week: Clearsense, Inc, Morningside Brands, Inc., Empirical Capital Secular Growth Fund, L.P., Timbertop Growth Investment Fund LLC, Hatchcares, Inc.
Esra Roan — Executive Officer (also: Director)
Rifat Pamukcu — Director
Brian Walsh — Director
Nathaniel Smith — Director
Corami Biotech Inc. filed a Form D with the SEC on April 22, 2026.